Skip to main content
Top
Published in: AIDS and Behavior 5/2015

Open Access 01-05-2015 | Original Paper

Communication About Microbicide Use Between Couples in KwaZulu-Natal, South Africa

Authors: Mitzy Gafos, Robert Pool, Misiwe Adelaide Mzimela, Hlengiwe Beauty Ndlovu, Sheena McCormack, Jonathan Elford, The MDP Team

Published in: AIDS and Behavior | Issue 5/2015

Login to get access

Abstract

The ways in which couples communicate about microbicides is likely to influence microbicide uptake and usage. We collected quantitative data about whether women in a microbicide trial discussed microbicides with their partners and explored communication about microbicides during 79 in-depth-interviews with women enrolled in the trial and 17 focus-group discussions with community members. After 4 weeks in the trial, 60 % of 1092 women had discussed microbicides with their partners; in multivariate analysis, this was associated with younger age, clinic of enrolment and not living in households that owned cattle. After 52 weeks, 84 % of women had discussed microbicides; in multivariate analysis, this was associated with not living in households that owned cattle, not living in a household that relied on the cheapest water source, allocation to 0.5 % PRO2000 gel and consistent gel adherence. Qualitative findings highlighted that women in committed relationships were expected to discuss microbicides with their partners and preferred to use microbicides with their partner’s knowledge. Women had different reasons for, and ways of, discussing microbicides and these were influenced by the couple’s decision-making roles. Although there was tolerance for the use of microbicides without a partner’s knowledge, the women who used microbicides secretly appeared to be women who were least able to discuss microbicides. In KwaZulu-Natal, socio-cultural norms informing sexual communication are amenable to microbicide introduction.
Literature
1.
go back to reference Abdool-Karim Q, Abdool-Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–74.CrossRefPubMedCentralPubMed Abdool-Karim Q, Abdool-Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–74.CrossRefPubMedCentralPubMed
3.
go back to reference Koo HA, Woodsong C, Dalberth B, Viswanathan M, Simons-Rudolph A. Context of acceptability of topical microbicides: sexual relationships. J Soc Issues. 2005;61(1):67–93.CrossRefPubMedCentralPubMed Koo HA, Woodsong C, Dalberth B, Viswanathan M, Simons-Rudolph A. Context of acceptability of topical microbicides: sexual relationships. J Soc Issues. 2005;61(1):67–93.CrossRefPubMedCentralPubMed
4.
go back to reference Carballo-Diéguez A, Balan IC, Morrow K, et al. Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050). AIDS Care. 2007;19(8):1026–31.CrossRefPubMed Carballo-Diéguez A, Balan IC, Morrow K, et al. Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050). AIDS Care. 2007;19(8):1026–31.CrossRefPubMed
5.
go back to reference Coggins C, Elias CJ, Atisook R, et al. Women’s preferences regarding the formulation of over-the-counter vaginal spermicides. AIDS. 1998;12(11):1389–91.CrossRefPubMed Coggins C, Elias CJ, Atisook R, et al. Women’s preferences regarding the formulation of over-the-counter vaginal spermicides. AIDS. 1998;12(11):1389–91.CrossRefPubMed
6.
go back to reference El-Sadr WM, Mayer KH, Maslankowski L, et al. Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women. AIDS. 2006;20(8):1109–16.CrossRefPubMed El-Sadr WM, Mayer KH, Maslankowski L, et al. Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women. AIDS. 2006;20(8):1109–16.CrossRefPubMed
7.
go back to reference Hoffman S, Morrow KM, Mantell JE, Rosen RK, Carballo-Diéguez A, Gai F. Covert use, vaginal lubrication, and sexual pleasure: a qualitative study of urban U.S. Women in a vaginal microbicide clinical trial. Arch Sex Behav. 2010;39(3):748–60.CrossRefPubMedCentralPubMed Hoffman S, Morrow KM, Mantell JE, Rosen RK, Carballo-Diéguez A, Gai F. Covert use, vaginal lubrication, and sexual pleasure: a qualitative study of urban U.S. Women in a vaginal microbicide clinical trial. Arch Sex Behav. 2010;39(3):748–60.CrossRefPubMedCentralPubMed
8.
go back to reference Morrow K, Rosen R, Richter L, et al. The acceptability of an investigational vaginal microbicide, PRO 2000 gel, among women in a phase I clinical trial. J Womens Health (Larchmt). 2003;12(7):655–66.CrossRef Morrow K, Rosen R, Richter L, et al. The acceptability of an investigational vaginal microbicide, PRO 2000 gel, among women in a phase I clinical trial. J Womens Health (Larchmt). 2003;12(7):655–66.CrossRef
9.
go back to reference Rosen RK, Morrow KM, Carballo-Diéguez A, et al. Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study. J Womens Health (Larchmt). 2008;17(3):383–92.CrossRef Rosen RK, Morrow KM, Carballo-Diéguez A, et al. Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study. J Womens Health (Larchmt). 2008;17(3):383–92.CrossRef
10.
go back to reference Carballo-Diéguez A, Giguere R, Dolezal C, et al. “Tell Juliana”: acceptability of the candidate microbicide VivaGel(R) and two placebo gels among ethnically diverse, sexually active young women participating in a phase 1 microbicide study. AIDS Behav. 2011;. doi:10.1007/s10461-011-0028-6.PubMedCentralPubMed Carballo-Diéguez A, Giguere R, Dolezal C, et al. “Tell Juliana”: acceptability of the candidate microbicide VivaGel(R) and two placebo gels among ethnically diverse, sexually active young women participating in a phase 1 microbicide study. AIDS Behav. 2011;. doi:10.​1007/​s10461-011-0028-6.PubMedCentralPubMed
11.
go back to reference Veldhuijzen N, Nyinawabega J, Umulisa M, et al. Preparing for microbicide trials in Rwanda: focus group discussions with Rwandan women and men. Cult Health Sex. 2006;8(5):395–406.CrossRefPubMed Veldhuijzen N, Nyinawabega J, Umulisa M, et al. Preparing for microbicide trials in Rwanda: focus group discussions with Rwandan women and men. Cult Health Sex. 2006;8(5):395–406.CrossRefPubMed
12.
go back to reference Ramjee G, Gouws E, Andrews A, Myer L, Weber A. The acceptability of a vaginal microbicide among South African men. Int Fam Plan Perspect. 2001;27(4):164–70.CrossRef Ramjee G, Gouws E, Andrews A, Myer L, Weber A. The acceptability of a vaginal microbicide among South African men. Int Fam Plan Perspect. 2001;27(4):164–70.CrossRef
13.
go back to reference van de Wijgert JH, Khumalo-Sakutukwa GN, Coggins C, et al. Men’s attitudes toward vaginal microbicides and microbicide trials in Zimbabwe. Int Fam Plan Perspect. 1999;25(1):15–20.CrossRef van de Wijgert JH, Khumalo-Sakutukwa GN, Coggins C, et al. Men’s attitudes toward vaginal microbicides and microbicide trials in Zimbabwe. Int Fam Plan Perspect. 1999;25(1):15–20.CrossRef
14.
go back to reference Coggins C, Blanchard K, Friedland B. Men’s attitudes towards a potential vaginal microbicide in Zimbabwe, Mexico and the USA. Reprod Health Matters. 2000;8(15):132–41.CrossRefPubMed Coggins C, Blanchard K, Friedland B. Men’s attitudes towards a potential vaginal microbicide in Zimbabwe, Mexico and the USA. Reprod Health Matters. 2000;8(15):132–41.CrossRefPubMed
15.
go back to reference Bisika T. Potential acceptability of microbicides in HIV prevention in stable marital relationships in Malawi. J Fam Plann Reprod Health Care. 2009;35(2):115–7.CrossRefPubMed Bisika T. Potential acceptability of microbicides in HIV prevention in stable marital relationships in Malawi. J Fam Plann Reprod Health Care. 2009;35(2):115–7.CrossRefPubMed
16.
go back to reference Salter ML, Go VF, Celentano DD, et al. The role of men in women’s acceptance of an intravaginal gel in a randomized clinical trial in Blantyre, Malawi: a qualitative and quantitative analysis. AIDS Care. 2008;20(7):853–62.CrossRefPubMed Salter ML, Go VF, Celentano DD, et al. The role of men in women’s acceptance of an intravaginal gel in a randomized clinical trial in Blantyre, Malawi: a qualitative and quantitative analysis. AIDS Care. 2008;20(7):853–62.CrossRefPubMed
17.
18.
go back to reference Green G, Pool R, Harrison S, et al. Female control of sexuality: illusion or reality? Use of vaginal products in south west Uganda. Soc Sci Med. 2001;52:585–98.CrossRefPubMed Green G, Pool R, Harrison S, et al. Female control of sexuality: illusion or reality? Use of vaginal products in south west Uganda. Soc Sci Med. 2001;52:585–98.CrossRefPubMed
19.
go back to reference Pool R, Whitworth JA, Green G, Mbonye AK, Harrison S, Wilkinson J, Hart GJ. An acceptability study of female-controlled methods of protection against HIV and STDs in south-western Uganda. Int J STD AIDS. 2000;11(3):162–7.CrossRefPubMed Pool R, Whitworth JA, Green G, Mbonye AK, Harrison S, Wilkinson J, Hart GJ. An acceptability study of female-controlled methods of protection against HIV and STDs in south-western Uganda. Int J STD AIDS. 2000;11(3):162–7.CrossRefPubMed
20.
go back to reference Montgomery CM, Lees S, Stadler J, et al. The role of partnership dynamics in determining the acceptability of condoms and microbicides. AIDS Care. 2008;20(6):733–40.CrossRefPubMed Montgomery CM, Lees S, Stadler J, et al. The role of partnership dynamics in determining the acceptability of condoms and microbicides. AIDS Care. 2008;20(6):733–40.CrossRefPubMed
21.
go back to reference Bentley ME, Fullem AM, Tolley EE, et al. Acceptability of a microbicide among women and their partners in a 4-country phase I trial. Am J Public Health. 2004;94(7):1159–64.CrossRefPubMedCentralPubMed Bentley ME, Fullem AM, Tolley EE, et al. Acceptability of a microbicide among women and their partners in a 4-country phase I trial. Am J Public Health. 2004;94(7):1159–64.CrossRefPubMedCentralPubMed
22.
go back to reference Turner AN, Van Damme K, Jamieson DJ, et al. Predictors of adherent use of diaphragms and microbicide gel in a four-arm, randomized pilot study among female sex workers in Madagascar. Sex Transm Dis. 2009;36(4):249–57.CrossRefPubMed Turner AN, Van Damme K, Jamieson DJ, et al. Predictors of adherent use of diaphragms and microbicide gel in a four-arm, randomized pilot study among female sex workers in Madagascar. Sex Transm Dis. 2009;36(4):249–57.CrossRefPubMed
23.
go back to reference Montgomery CM, Gafos M, Lees S, et al. Re-framing microbicide acceptability: findings from the MDP301 trial. Cult Health Sex. 2010;12(6):649–62.CrossRefPubMed Montgomery CM, Gafos M, Lees S, et al. Re-framing microbicide acceptability: findings from the MDP301 trial. Cult Health Sex. 2010;12(6):649–62.CrossRefPubMed
24.
go back to reference Rustomjee R, Abdool Karim Q, Abdool Karim SS, Laga M, Stein Z. Phase 1 trial of nonoxynol-9 film among sex workers in South Africa. AIDS. 1999;13(12):1511–5.CrossRefPubMed Rustomjee R, Abdool Karim Q, Abdool Karim SS, Laga M, Stein Z. Phase 1 trial of nonoxynol-9 film among sex workers in South Africa. AIDS. 1999;13(12):1511–5.CrossRefPubMed
25.
go back to reference Vandebosch A, Goetghebeur E, Ramjee G, et al. Acceptability of COL-1492, a vaginal gel, among sex workers in one Asian and three African cities. Sex Transm Infect. 2004;80(3):241–3.CrossRefPubMedCentralPubMed Vandebosch A, Goetghebeur E, Ramjee G, et al. Acceptability of COL-1492, a vaginal gel, among sex workers in one Asian and three African cities. Sex Transm Infect. 2004;80(3):241–3.CrossRefPubMedCentralPubMed
26.
go back to reference Greene E, Batona G, Hallad J, et al. Acceptability and adherence of a candidate microbicide gel among high-risk women in Africa and India. Cult Health Sex. 2010;12(7):739–54.CrossRefPubMed Greene E, Batona G, Hallad J, et al. Acceptability and adherence of a candidate microbicide gel among high-risk women in Africa and India. Cult Health Sex. 2010;12(7):739–54.CrossRefPubMed
27.
go back to reference Visness CM, Ulin P, Pfannenschmidt S, Zekeng L. Views of Cameroonian sex workers on a woman-controlled method of contraception and disease protection. Int J STD AIDS. 1998;9(11):695–9.CrossRefPubMed Visness CM, Ulin P, Pfannenschmidt S, Zekeng L. Views of Cameroonian sex workers on a woman-controlled method of contraception and disease protection. Int J STD AIDS. 1998;9(11):695–9.CrossRefPubMed
28.
go back to reference Woodsong C, Alleman P. Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi. AIDS Educ Prev. 2008;20(2):171–87.CrossRefPubMed Woodsong C, Alleman P. Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi. AIDS Educ Prev. 2008;20(2):171–87.CrossRefPubMed
29.
go back to reference Mantell JE, Needham SL, Smit JA, et al. Gender norms in South Africa: implications for HIV and pregnancy prevention among African and Indian women students at a South African tertiary institution. Cult Health Sex. 2009;11(2):139–57.CrossRefPubMedCentralPubMed Mantell JE, Needham SL, Smit JA, et al. Gender norms in South Africa: implications for HIV and pregnancy prevention among African and Indian women students at a South African tertiary institution. Cult Health Sex. 2009;11(2):139–57.CrossRefPubMedCentralPubMed
30.
go back to reference Orner P, Harries J, Cooper D, et al. Challenges to microbicide introduction in South Africa. Soc Sci Med. 2006;63(4):968–78.CrossRefPubMed Orner P, Harries J, Cooper D, et al. Challenges to microbicide introduction in South Africa. Soc Sci Med. 2006;63(4):968–78.CrossRefPubMed
31.
go back to reference MacPhail C, Terris-Prestholt F, Kumaranayake L, et al. Managing men: women’s dilemmas about overt and covert use of barrier methods for HIV prevention. Cult Health Sex. 2009;11(5):485–97.CrossRefPubMed MacPhail C, Terris-Prestholt F, Kumaranayake L, et al. Managing men: women’s dilemmas about overt and covert use of barrier methods for HIV prevention. Cult Health Sex. 2009;11(5):485–97.CrossRefPubMed
32.
go back to reference Ramjee G, Morar NS, Braunstein S, et al. Acceptability of Carraguard, a candidate microbicide and methyl cellulose placebo vaginal gels among HIV-positive women and men in Durban, South Africa. AIDS Res Ther. 2007;4:20.CrossRefPubMedCentralPubMed Ramjee G, Morar NS, Braunstein S, et al. Acceptability of Carraguard, a candidate microbicide and methyl cellulose placebo vaginal gels among HIV-positive women and men in Durban, South Africa. AIDS Res Ther. 2007;4:20.CrossRefPubMedCentralPubMed
33.
go back to reference Carraguard. Expanded safety and acceptability of the candidate vaginal microbicide Carraguard(R) in South Africa. Contraception. 2010;82(6):563–71.CrossRef Carraguard. Expanded safety and acceptability of the candidate vaginal microbicide Carraguard(R) in South Africa. Contraception. 2010;82(6):563–71.CrossRef
34.
go back to reference Hira SK, Spruyt AB, Feldblum PJ, et al. Spermicide acceptability among patients at a sexually transmitted disease clinic in Zambia. Am J Public Health. 1995;85(8 Pt 1):1098–103.CrossRefPubMedCentralPubMed Hira SK, Spruyt AB, Feldblum PJ, et al. Spermicide acceptability among patients at a sexually transmitted disease clinic in Zambia. Am J Public Health. 1995;85(8 Pt 1):1098–103.CrossRefPubMedCentralPubMed
35.
go back to reference van der Straten A, Moore J, Napierala S, et al. Consistent use of a combination product versus a single product in a safety trial of the diaphragm and microbicide in Harare, Zimbabwe. Contraception. 2008;77(6):435–43.CrossRefPubMed van der Straten A, Moore J, Napierala S, et al. Consistent use of a combination product versus a single product in a safety trial of the diaphragm and microbicide in Harare, Zimbabwe. Contraception. 2008;77(6):435–43.CrossRefPubMed
37.
go back to reference Tolley E, Friedland B, Gafos M. Socioeconomic and behavioural factors influencing choice, adherence and success of microbicide formulations. In: José das Neves BS, editor. Drug delivery and development of anti-HIV microbicides 2014. Tolley E, Friedland B, Gafos M. Socioeconomic and behavioural factors influencing choice, adherence and success of microbicide formulations. In: José das Neves BS, editor. Drug delivery and development of anti-HIV microbicides 2014.
38.
go back to reference Tanser F, Hosegood V, Bärnighausen T, et al. Cohort profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey. Int J Epidemiol. 2008;37(5):956–62.CrossRefPubMedCentralPubMed Tanser F, Hosegood V, Bärnighausen T, et al. Cohort profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey. Int J Epidemiol. 2008;37(5):956–62.CrossRefPubMedCentralPubMed
39.
go back to reference Nunn A, McCormack S, Crook AM, et al. Microbicides development programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention. Trials. 2009;10:99.CrossRefPubMedCentralPubMed Nunn A, McCormack S, Crook AM, et al. Microbicides development programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention. Trials. 2009;10:99.CrossRefPubMedCentralPubMed
40.
go back to reference McCormack S, Ramjee G, Kamali A, et al. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet. 2010;376(9749):1329–37.CrossRefPubMedCentralPubMed McCormack S, Ramjee G, Kamali A, et al. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet. 2010;376(9749):1329–37.CrossRefPubMedCentralPubMed
41.
go back to reference Pool R, Montgomery CM, Morar NS, et al. A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme. PLoS One. 2010;5(7):e11600.CrossRefPubMedCentralPubMed Pool R, Montgomery CM, Morar NS, et al. A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme. PLoS One. 2010;5(7):e11600.CrossRefPubMedCentralPubMed
42.
go back to reference Shisana O, Rehle T, Simbayi LC, Zuma K, Jooste S, Zungu N, Labadarios D, Onoya D, et al. South African National HIV prevalence, incidence and behaviour survey. Cape Town: HSRC Press; 2014. Shisana O, Rehle T, Simbayi LC, Zuma K, Jooste S, Zungu N, Labadarios D, Onoya D, et al. South African National HIV prevalence, incidence and behaviour survey. Cape Town: HSRC Press; 2014.
43.
go back to reference Tanser F, Bärnighausen T, Grapsa E, Zaidi J, Newell M-L. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339(6122):966–71.CrossRefPubMedCentralPubMed Tanser F, Bärnighausen T, Grapsa E, Zaidi J, Newell M-L. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339(6122):966–71.CrossRefPubMedCentralPubMed
44.
go back to reference Crook A, Gilbert, C., Birger, R. Final report for MDP 301 Centre Report. 2009. Crook A, Gilbert, C., Birger, R. Final report for MDP 301 Centre Report. 2009.
45.
go back to reference Gafos M, Mzimela M, Ndlovu H, et al. “One teabag is better than four”: Participants response to the discontinuation of 2% PRO2000/5 microbicide gel in KwaZulu-Natal, South Africa. PLoS One. 2011;6(1):e14577.CrossRefPubMedCentralPubMed Gafos M, Mzimela M, Ndlovu H, et al. “One teabag is better than four”: Participants response to the discontinuation of 2% PRO2000/5 microbicide gel in KwaZulu-Natal, South Africa. PLoS One. 2011;6(1):e14577.CrossRefPubMedCentralPubMed
46.
go back to reference Kirkwood B, Sterne J. Essential medical statistics. Oxford: Blackwell Science Ltd.; 2003. Kirkwood B, Sterne J. Essential medical statistics. Oxford: Blackwell Science Ltd.; 2003.
47.
go back to reference Gafos M, Pool R, Mzimela MA, et al. The implications of post-coital intravaginal cleansing for the introduction of vaginal microbicides in South Africa. AIDS Behav. 2014;18(2):297–310.CrossRefPubMedCentralPubMed Gafos M, Pool R, Mzimela MA, et al. The implications of post-coital intravaginal cleansing for the introduction of vaginal microbicides in South Africa. AIDS Behav. 2014;18(2):297–310.CrossRefPubMedCentralPubMed
48.
go back to reference Susser I. AIDS, sex, and culture: global politics and survival in Southern Africa. Oxford: Wiley-Blackwell; 2009.CrossRef Susser I. AIDS, sex, and culture: global politics and survival in Southern Africa. Oxford: Wiley-Blackwell; 2009.CrossRef
49.
go back to reference Ndinda C, Uzodike UO, Chimbwete C, Pool R. Gender relations in the context of HIV/AIDS in rural South Africa. AIDS Care. 2007;19(7):844–9.CrossRefPubMed Ndinda C, Uzodike UO, Chimbwete C, Pool R. Gender relations in the context of HIV/AIDS in rural South Africa. AIDS Care. 2007;19(7):844–9.CrossRefPubMed
50.
go back to reference Sahin-Hodoglugil NN, Montgomery E, Kacanek D, et al. User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa. AIDS Care. 2011;. doi:10.1080/09540121.2010.543879.PubMed Sahin-Hodoglugil NN, Montgomery E, Kacanek D, et al. User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa. AIDS Care. 2011;. doi:10.​1080/​09540121.​2010.​543879.PubMed
51.
go back to reference Berglund A-I. Zulu thought-patterns and symbolism. Uppsala: Indiana University Press; 1976. Berglund A-I. Zulu thought-patterns and symbolism. Uppsala: Indiana University Press; 1976.
52.
go back to reference Muhwava W. Trends of economic status of households in the ACDIS. Mtubatuba: Africa Centre for Health and Population Studies; 2007. Muhwava W. Trends of economic status of households in the ACDIS. Mtubatuba: Africa Centre for Health and Population Studies; 2007.
53.
go back to reference Montgomery ET, van der Straten A, Chidanyika A, et al. The importance of male partner involvement for women’s acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe. AIDS Behav. 2011;15(5):959–69.CrossRefPubMedCentralPubMed Montgomery ET, van der Straten A, Chidanyika A, et al. The importance of male partner involvement for women’s acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe. AIDS Behav. 2011;15(5):959–69.CrossRefPubMedCentralPubMed
54.
go back to reference Sahin-Hodoglugil NN, van der Straten A, Cheng H, et al. Degrees of disclosure: a study of women’s covert use of the diaphragm in an HIV prevention trial in sub-Saharan Africa. Soc Sci Med. 2009;69(10):1547–55.CrossRefPubMed Sahin-Hodoglugil NN, van der Straten A, Cheng H, et al. Degrees of disclosure: a study of women’s covert use of the diaphragm in an HIV prevention trial in sub-Saharan Africa. Soc Sci Med. 2009;69(10):1547–55.CrossRefPubMed
55.
go back to reference Gafos M, Mzimela M, Sukazi S, et al. Intravaginal insertion in KwaZulu-Natal: sexual practices and preferences in the context of microbicide gel use. Cult Health Sex. 2010;12(8):929–42.CrossRefPubMedCentralPubMed Gafos M, Mzimela M, Sukazi S, et al. Intravaginal insertion in KwaZulu-Natal: sexual practices and preferences in the context of microbicide gel use. Cult Health Sex. 2010;12(8):929–42.CrossRefPubMedCentralPubMed
56.
go back to reference Jewkes R, Nduna M, Levin J, et al. Impact of stepping stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial. BMJ. 2008;337:a506.CrossRefPubMedCentralPubMed Jewkes R, Nduna M, Levin J, et al. Impact of stepping stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial. BMJ. 2008;337:a506.CrossRefPubMedCentralPubMed
57.
go back to reference Jewkes R, Morrell R. Gender and sexuality: emerging perspectives from the heterosexual epidemic in South Africa and implications for HIV risk and prevention. J Int AIDS Soc. 2010;13(1):6.PubMedCentralPubMed Jewkes R, Morrell R. Gender and sexuality: emerging perspectives from the heterosexual epidemic in South Africa and implications for HIV risk and prevention. J Int AIDS Soc. 2010;13(1):6.PubMedCentralPubMed
59.
go back to reference Fladseth K, Gafos M, Newell M, McGrath N. More equitable gender norms are associated with higher levels of condom use at last sex act among HIV-positive men and women: rural KwaZulu-Natal, South Africa. South African AIDS Conference; 18–21 June 2013; Durban, South Africa 2013. Fladseth K, Gafos M, Newell M, McGrath N. More equitable gender norms are associated with higher levels of condom use at last sex act among HIV-positive men and women: rural KwaZulu-Natal, South Africa. South African AIDS Conference; 18–21 June 2013; Durban, South Africa 2013.
60.
go back to reference Mantell JE, Dworkin SL, Exner TM, et al. The promises and limitations of female-initiated methods of HIV/STI protection. Soc Sci Med. 2006;63(8):1998–2009.CrossRefPubMedCentralPubMed Mantell JE, Dworkin SL, Exner TM, et al. The promises and limitations of female-initiated methods of HIV/STI protection. Soc Sci Med. 2006;63(8):1998–2009.CrossRefPubMedCentralPubMed
61.
go back to reference Jewkes RK, Dunkle K, Nduna M, Shai N. Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study. Lancet. 2010;376(9734):41–8.CrossRefPubMed Jewkes RK, Dunkle K, Nduna M, Shai N. Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study. Lancet. 2010;376(9734):41–8.CrossRefPubMed
Metadata
Title
Communication About Microbicide Use Between Couples in KwaZulu-Natal, South Africa
Authors
Mitzy Gafos
Robert Pool
Misiwe Adelaide Mzimela
Hlengiwe Beauty Ndlovu
Sheena McCormack
Jonathan Elford
The MDP Team
Publication date
01-05-2015
Publisher
Springer US
Published in
AIDS and Behavior / Issue 5/2015
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0965-y

Other articles of this Issue 5/2015

AIDS and Behavior 5/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.